YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Onyx Pharma Could Draw $180 Per Share

July 1, 2013 | Over the weekend, Onyx Pharmaceuticals stirred up speculation over a buyout. Amgen reportedly offered $120/share, and Onyx responded by issuing a call for other suitors. This morning, pundits speculate that the price could hit $180/share. Forbes
View Next Related Story
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.